Womble Bond Dickinson hosted a panel discussion on the current challenges involving data retention and e-discovery. In particular, the session looked at employee use of personal devices for business purposes, as well as a growing trend by digital messaging platforms to automatically delete messages shortly after they are delivered. This article is taken from that panel discussion.
Learn about how to navigate uncertainties regarding the EU-US "agreement in principle" on the data privacy framework announced in March 2022.
Learn about the effects of California's Broad Pay Transparency law on pay disclosure and pay data requirement in California and similar movements in other states.
The Personalized Medicine Coalition (PMC) recently released its annual report on the progress of precision medicine as measured by precision medicine FDA approvals in 2022 (“Report”). As summarized in the Report, 2022 milestones include progress in diagnostics, therapeutics and new treatment modalities that are covered in this resource from Foley and Lardner LLP.
With the pandemic, there came a digital health explosion, with companies working swiftly to bring new technologies to light that would pave the way forward in telehealth and other critical areas. We saw an incredible interest in this space then, but what is the state of digital health now? This resource from Foley & Lardner LLP looks at data from public and private financing markets in the digital health space in 2022, and look forward to what to expect in 2023.
With the health care industry under pressure to improve patient outcomes while controlling costs, artificial intelligence (AI) and machine learning (ML) are quickly becoming indispensable tools. These technologies show promise in supporting decision-making, enhancing the delivery of care, and personalizing medicine. This resource from Foley & Lardner explores opportunities for health care organizations deploying AI-based solutions.
This resource provided by Foley & Lardner LLP covers the DOJ’s announcement on February 6th of their withdrawal of the 2011 Statement of Antitrust Enforcement Policy Regarding Accountable Care Organizations Participating in the Medicare Shared Savings Program (2011 ACO Statement) in addition to two other health care antitrust policy statements.
This resource from Seyfarth & Shaw LLP discusses the Securities and Exchange Commission's proposal for three new sets of rules (the “Proposed Rules”), as well as key considerations for the future based on this proposal.
This resource from Seyfarth Shaw LLP discusses the appropriate considerations and actions concerning the FDIC for those with loans in a Bridge Bank.
Learn about the developments around the EU-US Trans-Atlantic Data Privacy Framework announced March 2022.